Tfa Therapeutics(OTC) RAJAF

Market Cap$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+12,900%
5 YearN/A
1 Year-37%
1 Month+0%
$5.20
+72.76%
+2.19Today
Tfa Therapeutics last closing stock price
MetricPriceDate
Last closeUSD 5.202025-12-31
Tfa Therapeutics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 5.202025-11-07
1 month+0%USD 5.202025-11-07
3 month-43.36%USD 9.182025-07-09
Year to date-36.97%USD 8.252024-12-23
1 year-36.97%USD 8.252024-12-23
Since inception+12,900%USD 0.042024-07-19

Tfa Therapeutics Financials at a Glance

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$5.20

Volume

1

Open

$5.20

Previous Close

$5.20

Daily Range

$4.85 - $5.20

52-Week Range

$3.01 - $9.18

Estimated Earnings Date

N/A

RAJAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tfa Therapeutics

Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in the cultivating and sale of cordyceps. It engages in the research, development, manufacturing, and marketing of cordyceps, through its wholly-owned subsidiary, Chengdu Skyherb Biotechnology Co., Ltd. The company was founded on May 4, 2020 and is headquartered in Taipei, Taiwan.

Industry

Personal Products

Sector

Consumer Staples

Employees

16

CEO

Szu Hao Huang

Website

cordyceps-sunshine.com

RAJAF Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.12M

Volume

1

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Tfa Therapeutics Performance Analysis

Tfa Therapeutics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 53,304-93.9%
20232023-12-31USD 882,5331555.7%
20242024-12-31USD 1,253,48442.0%
20252025-12-31USD 1,245,348-0.6%
Tfa Therapeutics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0156.8%
20232023-12-31USD -0.00-85.5%
20242024-12-31USD -0.00100.0%
20252025-12-31USD -0.00-30.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About RAJAF

What is the current price of Tfa Therapeutics?

Tfa Therapeutics is trading at $5.20 per share.

What is the 52-week range for Tfa Therapeutics?

Over the past 52 weeks, Tfa Therapeutics has traded between $3.01 and $9.18.

How much debt does Tfa Therapeutics have?

As of the most recent reporting period, Tfa Therapeutics reported total debt of $718.52K.

How much cash does Tfa Therapeutics have on hand?

Tfa Therapeutics reported $3.20K in cash and cash equivalents in its most recent financial results.

What is Tfa Therapeutics’s dividend yield?

Tfa Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services